Bloom Energy: The Fuel-Cell Darling Caught Between a Billion-Dollar Pipeline and a Legal Cloud

Bloom Energy's stock falls 4.63% despite record Q2 revenue of $1.065B and expanding AI customer base, as market weighs growth against skepticism.

The market's verdict on Bloom Energy this week reads like a study in contradiction. The fuel-cell manufacturer closed Friday's session at €189.60, down 4.63 percent on the day, even as the company's order book fills with marquee AI-infrastructure deals and its quarterly numbers smash through the billion-dollar mark for the first time. For investors, the tension is no longer about whether demand exists — it's about whether the story can outrun the skepticism.

A Deeper Customer Base Than Anyone Knew

The most telling detail to emerge in recent weeks isn't a headline deal but a quiet disclosure: Bloom now serves nearly two dozen customers in the AI-infrastructure space, a roster that stretches well beyond the familiar names of Oracle, Nebius, Brookfield, AEP, and Equinix. That breadth matters because it undercuts the narrative that Bloom is a one-trick pony dependent on a handful of hyperscalers.

The company's expanded partnership with MiTAC Computing Technology illustrates the playbook. Bloom is now building an island microgrid — an autonomous power network — for MiTAC's AI server manufacturing campus in Fremont, California, supplementing an existing installation in San Jose. The model is consistent across geographies: bypass the grid entirely, generate power on-site, and get AI infrastructure online in months rather than years.

That same logic underpins the July announcement of $1.7 billion in project financing from Industrial Development Funding and Oaktree, earmarked for expanding Bloom's fuel-cell footprint to support Nebius's AI operations. And in a separate arrangement, American Electric Power has committed to taking up to a gigawatt of fuel-cell capacity. South Korea adds another front, with partnerships at SK Ecoplant and SK Eternix.

The Numbers That Fuel the Bull Case

The second-quarter results, reported on July 28, gave the bulls their ammunition. Revenue hit a record $1.065 billion — up 166 percent year over year and the first time the company has crossed the billion-dollar threshold. GAAP operating income swung from a year-ago loss to a profit of $182.2 million. Management raised full-year revenue guidance to a range of $3.9 billion to $4.2 billion and signaled meaningfully higher earnings per share than previously guided.

The stock's reaction to those numbers was telling in its own way. After jumping roughly 7 to 8 percent in after-hours U.S. trading, the shares reversed course the next day and closed at $163.75. The market, it seems, is pricing in more than just the quarterly scorecard.

Analyst targets reflect the divergence. Evercore ISI's Nicholas Amicucci reaffirmed a Buy rating and a $350 price target on Tuesday, following the MiTAC news. JPMorgan's Mark Strouse trimmed his target to $314 but kept an Overweight rating. Mizuho's Maheep Mandloi upgraded the stock from Neutral to Outperform with a $242 target, arguing the operating leverage is materializing faster than expected. Roth Capital, Truist, and Wells Fargo all cut their targets while holding ratings steady. The consensus target sits at €236.57, implying roughly 25 percent upside from Friday's close — but the spread between the most and least enthusiastic calls is wide.

The Bearish Counterweight

The skeptics have their own data points. Hunterbrook Capital published a report on July 8 alleging Bloom has a hidden dependence on Chinese suppliers for scandium, a rare earth metal used in its fuel cells. The stock fell 5.7 percent that day. Bloom rebutted the claims in a regulatory filing, calling them false and misleading. A follow-up report went further, asserting that Bloom's solid-oxide fuel cells fall below key performance thresholds after roughly 20 months at many installations — well short of the promised five-year lifespan.

The legal machinery is now in motion. A shareholder class action was filed in late July in the U.S. District Court for the Northern District of California, accusing Bloom of underestimating its China supply-chain risks and scandium dependency. The class period runs from February 27, 2025, through July 8, 2026. Several firms — Kaplan Fox, Bronstein Gewirtz & Grossman, Robbins LLP, and Rosen Law Firm — are soliciting lead plaintiffs ahead of a September 28, 2026 deadline.

Insider selling under pre-arranged trading plans adds a quieter but persistent drag on sentiment. It's not a red flag in itself, but it does little to reassure investors paying a premium for growth.

A Chart That Tells Its Own Story

The technical picture captures the volatility. The stock sits 38.54 percent below its 52-week high of €308.50 and has fallen 14.79 percent over the past 30 days. The 14-day RSI at 47.3 suggests a neutral, consolidating market — neither overbought nor oversold. Annualized 30-day volatility stands at 130.95 percent, a figure more typical of cryptocurrencies than an established energy-technology company.

Yet the longer-term trend remains intact. The stock is still up 152.63 percent year to date and 500.19 percent over the past twelve months. It trades 19.75 percent above its 200-day moving average, though that gap has narrowed from recent levels. A return to the 50-day average at €221.58 would signal stabilizing sentiment; a slide to the 200-day average at €158.34 would mark a deeper correction.

What Happens Next

The near-term catalysts are concrete. Progress updates on the Nebius project and the delivery schedule under the AEP agreement will show whether announcements are converting into revenue. Additional hyperscaler deals would strengthen the path toward the consensus target.

The bear case rests on execution risk: supply-chain disruptions, margin compression, or delays in scaling production could erode the premium the market currently grants the stock. Rising capital costs or a slowdown in data-center investment would compound the pressure.

For now, the operational substance outweighs the legal overhang — but the combination of a class action, short-seller scrutiny, and a wide analyst target range suggests the wild swings at Bloom Energy are likely to be the norm rather than the exception for the foreseeable future.